Long-term therapy of IDDM with an implantable insulin pump

Diabetes Care

Volumn 20, Issue 1, 1997, Pages 59-63

  Dunn, Fredrick L ^a,f   Nathan, David M ^b   Scavini, Marina ^e   Selam, Jean Louis ^d   Wingrove, Theresa G ^c  

^a DUKE UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Strato/Infusaid   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ARTICLE; CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031028603     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.1.59     Document Type: Article

References (20)

1. Diabetes Control and Complications Research Group: The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Selam J-L, Charles MA: Devices for insulin administration. Diabetes Care 13:955-979, 1990
3. Saudek CD, Selam JL, Pitt HA, Waxman K, Rubio M, Turner D, Jeandidier N, Charles MA, Fischell RE: A preliminary trial with the programmable implantable medication system for insulin delivery. N Engl J Med 321:575-579, 1989
4. Selam JL, Micossi P, Dunn FL, Nathan DM, the Implantable Insulin Pump Trial Study Group: Clinical trial of programmable implantable insulin pump for type I diabetes. Diabetes Care 15:877-885, 1992
5. Broussolle C, Jeandidier N, Hanaire BH: French multicenter experience of implantable insulin pumps: the EVADIAC study group: evaluation of active implants. Lancet i:514-515, 1994
6. DCCT Research Group: Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial. Diabetes Care 11:725-732, 1988
7. Nathan DM: Labile glycosylated hemoglobin contributes to hemoglobin A1c as measured by liquid chromatography or electrophoresis. Clin Chem 27:1261-1263, 1981
8. Scavini M, Galli L, Reich S, Eaton RP, Charles MA, Dunn FL, the Implantable Insulin Pump Trial Study Group: Catheter survival during long-term insulin therapy with an implanted programmable pump. Diabetes Care (In press)
9. DCCT Research Group: Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study Clin Chem 33:2267-2271, 1987
10. Scavini M, Reich S, Eaton RP, Charles MA, Dunn FL, the Implantable Insulin Pump Trial Study Group: Use on an integrated sideport for diagnosis and management of decreased flow rates in a programmable implanted insulin delivery system. Int J Artif Organs 20:991-996, 1996
11. Scavini M, Cristallo M, Sarmiento M, Dunn FL, the Infusaid Multicenter Implantable Insulin Pump Study Group: Pump-pocket complications during long-term insulin delivery using an implanted programmable pump. Diabetes Care 19:384-385, 1996
12. Nathan DM, Dunn FL, Bruch J, McKitrick C, Larkin M, Haggan C, Lavin-Tompkins J, Norman D, Roger D, Simon D: Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Am J Med 100:412-417, 1996
13. Salem JL, Medlej R, M'bemba J, Chevalier A, Guyon F, Ashworth L, Slama G: Symptoms, hormones, and glucose fluxes during a gradual hypoglycaemia induced by intraperitoneal vs. venous insulin infusion in type I diabetes. Diabet Med 12:1102-1109, 1995
14. Duckworth WC, Saudek CD, Henry RR: Why intraperitoneal delivery of insulin with implantable pumps in NIDDM? Diabetes 41:657-661, 1992
15. Selam JL, Kashyap M, Alberti K, Lozano J, Hanna M, Turner D, Jeandidier N, Chan E, Charles MA: Comparison of iniraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type 1 diabetes mellitus. Metabolism 38:908-912, 1989
16. Georgopoulos A, Saudek CC: Normalization of composition of triglyceride-rich lipoprotein subfractions in diabetic subjects during insulin infusion with programmable implantable medication system. Diabetes Care 15:19-26, 1992
17. Bagdade JD, Dunn FL, Eckel RH, Ritter MC: Intraperitoneal insulin therapy corrects abnormalities in cholesterol ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus. Arteriocler Thromb 14:1933-1939, 1994
18. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987
19. Bagdade J, Helve E, Taskinen M-R: Effects of continuous insulin infusion therapy on lipoprotein surface and core Lipid composition in IDDM. Metabolism 40:445-449, 1991
20. Bagdade J, Ritter M, Subbaiah P: Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 21:161-167, 1991